Haleon PLC Completes Share Buyback Program

Haleon PLC Sponsored ADR ( (HLN) ) just unveiled an update.

On May 29, 2025, Haleon PLC announced the completion of a share buyback transaction, purchasing 801,393 ordinary shares for cancellation, as part of its buyback programme initiated on March 28, 2025. This move reduces the company’s share capital to 9,006,925,287 ordinary shares, with 9,002,845,082 shares holding voting rights, potentially impacting shareholder interests and market positioning by consolidating ownership and possibly enhancing shareholder value.

The most recent analyst rating on (HLN) stock is a Buy with a $13.40 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.

Spark’s Take on HLN Stock

According to Spark, TipRanks’ AI Analyst, HLN is a Outperform.

Haleon’s strong financial performance, characterized by robust cash flow and stable profitability, is a key strength, complemented by positive technical indicators suggesting upward momentum. However, the stock’s valuation appears high, and recent earnings call highlights both opportunities in emerging markets and challenges like FX headwinds and product performance issues. These factors collectively position the stock at a solid yet cautious 73.1 score.

To see Spark’s full report on HLN stock, click here.

More about Haleon PLC Sponsored ADR

Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with a human touch. The company’s diverse product portfolio includes categories such as Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its trusted brands like Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren, which are grounded in scientific innovation and deep consumer understanding.

Average Trading Volume: 14,764,087

Technical Sentiment Signal: Buy

Current Market Cap: $50.03B

Learn more about HLN stock on TipRanks’ Stock Analysis page.